Targeting immunotherapy in multiple sclerosis: a near hit and a clear miss

Editorial

S R Schwid et al. Neurology. 1999.

. 1999 Aug 11;53(3):444-5.

doi: 10.1212/wnl.53.3.444.

No abstract available

Comment on

TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
[No authors listed] [No authors listed] Neurology. 1999 Aug 11;53(3):457-65. Neurology. 1999. PMID: 10449104 Clinical Trial.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Tubridy N, Behan PO, Capildeo R, Chaudhuri A, Forbes R, Hawkins CP, Hughes RA, Palace J, Sharrack B, Swingler R, Young C, Moseley IF, MacManus DG, Donoghue S, Miller DH. Tubridy N, et al. Neurology. 1999 Aug 11;53(3):466-72. doi: 10.1212/wnl.53.3.466. Neurology. 1999. PMID: 10449105 Clinical Trial.